Nasdaq:US$13.89 (+0.03) | HKEX:HK$22.45 (+0.50) | AIM:£2.07 (+0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729